BRCA1 and cancer: While this is sometimes achieved via compensatory mechanisms, such as increased activity of RAD52, studies have also demonstrated secondary somatic reversion of mutated genes in the DDR pathway, such as in BRCA1/2 and RAD51 genes, which can restore their function in cancer cells [68,109].